Cargando…

Correction: GPR110 promotes progression and metastasis of triple-negative breast cancer

Detalles Bibliográficos
Autores principales:	Nam, Hye-Jung, Kim, Yeon-Ju, Kang, Jae-Hyeok, Lee, Su-Jae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729180/ https://www.ncbi.nlm.nih.gov/pubmed/36476837 http://dx.doi.org/10.1038/s41420-022-01266-0

Ejemplares similares

GPR110 promotes progression and metastasis of triple-negative breast cancer
por: Nam, Hye-Jung, et al.
Publicado: (2022)

Correction: ICAM-1 promotes cancer progression by regulating SRC activity as an adapter protein in colorectal cancer
por: Lim, Eun-Ji, et al.
Publicado: (2022)

The role of GPR110 in lung cancer progression
por: Ma, Benting, et al.
Publicado: (2020)

Correction: triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
por: Choi, Yoon-La, et al.
Publicado: (2011)

Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer
por: Andradas, Clara, et al.
Publicado: (2016)

Correction: GPR119 agonist enhances gefitinib responsiveness through lactate-mediatedinhibition of autophagy
por: Im, Ji Hye, et al.
Publicado: (2022)

Correction: Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

Author Correction: Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles
por: Kannan, Anbarasu, et al.
Publicado: (2020)

Correction to: Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer
por: Zheng, Shaoquan, et al.
Publicado: (2020)

Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial
por: Jank, Paul, et al.
Publicado: (2021)

GPR87 Promotes Metastasis through the AKT-eNOS-NO Axis in Lung Adenocarcinoma
por: Ahn, Hye-Mi, et al.
Publicado: (2021)

Correction to: Molecular analyses of triple-negative breast cancer in the young and elderly
por: Aine, Mattias, et al.
Publicado: (2021)

Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2016)

Correction: MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer
por: Goode, Gennifer, et al.
Publicado: (2017)

Correction: Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors
por: Necela, Brian M., et al.
Publicado: (2015)

Correction: WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer
por: Ertay, Ayse, et al.
Publicado: (2021)

Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
por: Liang, Sixian, et al.
Publicado: (2022)

Author Correction: Succinate promotes stem cell migration through the GPR91-dependent regulation of DRP1-mediated mitochondrial fission
por: Ko, So Hee, et al.
Publicado: (2018)

Correction to: Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis
por: Chaudhary, Pankaj, et al.
Publicado: (2020)

Correction: Targeted Inactivation of GPR26 Leads to Hyperphagia and Adiposity by Activating AMPK in the Hypothalamus
por: Chen, Daohong, et al.
Publicado: (2012)

ICAM-1 promotes cancer progression by regulating SRC activity as an adapter protein in colorectal cancer
por: Lim, Eun-Ji, et al.
Publicado: (2022)

Correction: Modeling differentiation-state transitions linked to therapeutic escape in triple-negative breast cancer
por: Chapman, Margaret P., et al.
Publicado: (2019)

Correction for: A novel fatty-acid metabolism-based classification for triple negative breast cancer
por: Yang, Xia, et al.
Publicado: (2023)

Methionine deprivation suppresses triple-negative breast cancer metastasis in vitro and in vivo
por: Jeon, Hyein, et al.
Publicado: (2016)

Correction: BAG3 promotes tumour cell proliferation by regulating EGFR signal transduction pathways in triple negative breast cancer
por: Shields, Sarah, et al.
Publicado: (2019)

Correction to: Transcriptional activation of CBFβ by CDK11(p110) is necessary to promote osteosarcoma cell proliferation
por: Feng, Yong, et al.
Publicado: (2019)

Clinical Significance of G Protein-Coupled Receptor 110 (GPR110) as a Novel Prognostic Biomarker in Osteosarcoma
por: Liu, Zhiqiang, et al.
Publicado: (2018)

Orphan receptor GPR110, an oncogene overexpressed in lung and prostate cancer
por: Lum, Amy M, et al.
Publicado: (2010)

Correction: GPR50 is the mammalian ortholog of Mel1c: Evidence of rapid evolution in mammals
por: Dufourny, Laurence, et al.
Publicado: (2012)

Correction to: GPR68 deletion impairs hippocampal long-term potentiation and passive avoidance behavior
por: Xu, Yuanyuan, et al.
Publicado: (2021)

Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer
por: de Heer, E. C., et al.
Publicado: (2023)

Correction to: Hemostatic efcacy of a fowable collagen-thrombin matrix during coronary artery bypass grafting: a double-blind randomized controlled trial
por: Kim, Hyo-Hyun, et al.
Publicado: (2023)

Correction to: Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial
por: Lee, Hyuk, et al.
Publicado: (2017)

Correction to ‘The DNA repair function of BCL11A suppresses senescence and promotes continued proliferation of triple-negative breast cancer cells’
Publicado: (2023)

Correction: RIPK1-dependent necroptosis promotes vasculogenic mimicry formation via eIF4E in triple-negative breast cancer
por: Li, Fan, et al.
Publicado: (2023)

Author Correction: DNA methylation landscape of triple-negative ductal carcinoma in situ (DCIS) progressing to the invasive stage in canine breast cancer
por: Beetch, Megan, et al.
Publicado: (2020)

Correction: NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer
por: Ademuyiwa, Foluso O., et al.
Publicado: (2012)

Correction: Expression of Dickkopf-1 and Beta-Catenin Related to the Prognosis of Breast Cancer Patients with Triple Negative Phenotype
Publicado: (2014)

Correction: Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer
Publicado: (2021)

Correction: PARP targeted Auger emitter therapy with [(125)I]PARPi-01 for triple-negative breast cancer
por: Sankaranarayanan, Ramya Ambur, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jfhu5i57eu9tdf4e96bk9t66mb